0

CLARITIN از شرکت BAYER HEALTHCARE LLC

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CLARITIN از شرکت BAYER HEALTHCARE LLC

New Drug Application (NDA): 020641

Company: BAYER HEALTHCARE LLC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CLARITIN LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter

None

Yes Yes
CLARITIN HIVES RELIEF LORATADINE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** SYRUP;ORAL Discontinued

None

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/10/1996 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/28/2019 SUPPL-46 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020641Orig1s046lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020641Orig1s046ltr.pdf

05/14/2018 SUPPL-45 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020641Orig1s045lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020641Orig1s045ltr.pdf

08/09/2016 SUPPL-42 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020641Orig1s042lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020641Orig1s042ltr.pdf

02/12/2016 SUPPL-41 Manufacturing (CMC)

Label is not available on this site.

12/30/2015 SUPPL-40 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s040lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s040ltr.pdf

12/10/2015 SUPPL-39 Manufacturing (CMC)

Label is not available on this site.

11/12/2015 SUPPL-38 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s038lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s038ltr.pdf

10/21/2015 SUPPL-37 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641s037lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s037ltr.pdf

04/16/2015 SUPPL-36 Manufacturing (CMC)

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s036lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s036ltr.pdf

05/15/2014 SUPPL-35 Manufacturing (CMC)

Label is not available on this site.

04/16/2013 SUPPL-33 Manufacturing (CMC)

Label is not available on this site.

02/28/2013 SUPPL-32 Manufacturing (CMC)

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020641Orig1s032lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020641Orig1s032ltr.pdf

11/20/2012 SUPPL-30 Manufacturing (CMC)

Label is not available on this site.

07/25/2008 SUPPL-25 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020641s025ltr.pdf

07/25/2008 SUPPL-24 Labeling-Package Insert, Labeling-Container/Carton Labels

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020641s024ltr.pdf

06/14/2005 SUPPL-18 Manufacturing (CMC)-Formulation

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020641s018ltr.pdf

10/27/2004 SUPPL-17 Manufacturing (CMC)-Control

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20641s017ltr.pdf

07/15/2004 SUPPL-16 Manufacturing (CMC)-Packaging

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20641s016ltr.pdf

12/09/2002 SUPPL-12 Manufacturing (CMC)-Packaging

Label is not available on this site.

11/19/2003 SUPPL-11 Efficacy-Rx To OTC Switch

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/19658se6-020,20704se6-009,20641se6-011ltr.pdf

07/23/2002 SUPPL-10 Manufacturing (CMC)-Expiration Date

Label is not available on this site.

11/27/2002 SUPPL-9 Efficacy-Rx To OTC Switch

Letter (PDF)

Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19658se6-018,20704se6-008,20641se6-009ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/19670s18,20470s16,19658s18,20704s8,20641s9_Claritin.cfm

12/04/2000 SUPPL-7 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20641s7lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-641S007_Loratadine_Approv.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-641s007_LoratadineClaritin.cfm

01/07/1999 SUPPL-6 Manufacturing (CMC)-Formulation

Label is not available on this site.

10/29/1998 SUPPL-3 Manufacturing (CMC)

Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/1998/019670_s012,19658s14,20470s7,20641s3,20704s4_ClaritinDTOC.cfml

03/30/1998 SUPPL-2 Labeling

Label is not available on this site.

01/23/1998 SUPPL-1 Manufacturing (CMC)

Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/1998/019670_s008,19658s10,20470s3,20641s120704s3_Claritin-DTOC.cfml

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/28/2019 SUPPL-46

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020641Orig1s046lbl.pdf
05/14/2018 SUPPL-45

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020641Orig1s045lbl.pdf
08/09/2016 SUPPL-42

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020641Orig1s042lbl.pdf
12/30/2015 SUPPL-40

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s040lbl.pdf
11/12/2015 SUPPL-38

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s038lbl.pdf
10/21/2015 SUPPL-37

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641s037lbl.pdf
04/16/2015 SUPPL-36

Manufacturing (CMC)

Label (PDF)

This supplement type does not usually require new labeling.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s036lbl.pdf
02/28/2013 SUPPL-32

Manufacturing (CMC)

Label (PDF)

This supplement type does not usually require new labeling.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020641Orig1s032lbl.pdf
12/04/2000 SUPPL-7

Efficacy-New Patient Population

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20641s7lbl.pdf

CLARITIN

The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.

SYRUP;ORAL; 1MG/ML
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD Application No. Company
CLARITIN LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter Yes 020641 BAYER HEALTHCARE LLC
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 208931 AUROBINDO PHARMA LTD
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 210409 HETERO LABS LTD III
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 077421 LANNETT CO INC
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 075728 PERRIGO
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 076805 TARO
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 201865 TARO
LORATADINE LORATADINE 1MG/ML SYRUP;ORAL Over-the-counter No 075815 WOCKHARDT BIO AG

CLARITIN HIVES RELIEF

There are no other OTC drugs with the same Active Ingredient, Strength and Dosage Form/Route.

بخوانید  ABACAVIR SULFATE از شرکت AUROBINDO PHARMA LTD
برچسب‌ها:,

نظرات کاربران